Rotavirus vaccines: Current controversies and future directions

被引：4

作者：

Coffin S.E. ^{[1
]}

机构：

[1] Division of Immunologic and Infectious Diseases, The Children’s Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, 19104, PA

来源：

Current Infectious Disease Reports | 2000年 / 2卷 / 1期

关键词：

Intussusception; Reassortant Vaccine; Vaccine Adverse Event Reporting System;

D O I：

10.1007/s11908-000-0090-0

中图分类号：

学科分类号：

摘要：

Rotaviruses are the most important cause of pediatric gastroenteritis worldwide. In August 1998, a new rotavirus vaccine was licensed for general use in the United States. However, 14 months later, the vaccine was withdrawn from the market because of serious gastrointestinal side effects. This paper discusses the need for a rotavirus vaccine, the development of the first rotavirus vaccine, and the safety issues that led to the recall of that vaccine. © 2000, Current Science Inc.

引用

页码：68 / 72

页数：4

共 47 条

[1]

Glass R.I., Kilgore P.E., Holman R.C., Et al., The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden, J Infect Dis, 174, pp. S5-S11, (1996)

[2]

Huilan S., Zhen L.G., Mathan M.M., Et al., Etiology of acute diarrhoea among children in developing countries: a multicenter study in five countries, Bull WHO, 69, pp. 549-555, (1991)

[3]

Murray C.J., Lopez A.D., Global mortality, disability, and the contribution of risk factors: global burden of disease study, Lancet, 349, pp. 1436-1442, (1997)

[4]

Ardern-Holmes S.L., Lennon D., Pinnock R., Et al., Trends in hospitalization and mortality from rotavirus disease in New Zealand infants, Pediatr Infect Dis J, 18, pp. 614-619, (1999)

[5]

Parashar U.D., Holman R.C., Clarke M.J., Et al., Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995

[6]

surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code, J Infect Dis, 177, pp. 13-17, (1997)

[7]

Smith J.C., Haddix A.C., Teutsch S.M., Glass R.I., Cost-effectiveness analysis of a rotavirus immunization program for the United States, Pediatrics, 96, pp. 609-615, (1998)

[8]

Tucker A.W., Haddix A.C., Bresee J.S., Et al., Cost-effectiveness analysis of a rotavirus immunization program for the United States, JAMA, 279, pp. 1371-1376, (1998)

[9]

Matson D.O., Estes M.K., Impact of rotavirus infection at a large pediatric hospital, J Infect Dis, 162, pp. 598-604, (1990)

[10]

Carr M., McKendrick D., Spyridakis T., The clinical features of infantile gastroenteritis due to rotavirus, Scand J Infect Dis, 8, pp. 241-243, (1987)

← 1 2 3 4 5 →